Drug Database
Back to search

Netherlands· NL-0ff7fd55688a

Fasenra 30 mg oplossing voor injectie in voorgevulde spuit

A benralizumab product containing benralizumab, registered in Netherlands by AstraZeneca AB. The same ATC class is registered in 16 of our 19 countries.

ATC R03DX10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFasenra 30 mg oplossing voor injectie…ATCR03DX10REGISTER NO.NL-0ff7fd55688aPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about benralizumabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Benralizumab is registered in 16 of 19 countries.

Countries holding a registration under ATC R03DX10 (benralizumab), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search benralizumab products by name

Benralizumab · ATC R03DX10

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BENRALIZUMAB
Manufacturer
AstraZeneca AB
Country
Netherlands (NL)
ATC code
R03DX10
ATC class
Benralizumab
Defined daily dose
0.54 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1252

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Benralizumab in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benralizumab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Fasenra
  • Liechtenstein · Fasenra
  • Norway · Fasenra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd3ad8dc-c7a2-4cbc-b873-cd7195972ddc
GET /v1/drugs/dd3ad8dc-c7a2-4cbc-b873-cd7195972ddc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/fasenra-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Benralizumab",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120336",
  "excipients": [
    "HISTIDINE, (L-)",
    "HISTIDINEMONOHYDROCHLORIDE 1-WATER (L-)",
    "POLYSORBAAT 20 (E 432)",
    "TREHALOSE (Alpha, Alpha-)  2-WATER",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "BENRALIZUMAB"
  ],
  "leaflet_url": null,
  "authorised_at": "2018/01/08",
  "procedure_number": "EMEA/H/C/004433",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1252",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about benralizumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console